Novo Nordisk NVO announced plans to advance amycretin, for weight management, into late-stage development. Amycretin is being ...

Private equity has been slowing for years. But without public markets to dictate prices, it’s been easy to ignore the impact ...

Novo Nordisk jumps 5% as Parvus Asset Management builds a stake to sway CEO succession amid leadership shakeup and pipeline ...

European shares closed little changed on Tuesday in cautious trade as investors awaited the outcome of the second day of U.S.

Bloomberg says Zuckerberg has prioritized recruiting for the new team, referred internally as a “superintelligence group.” He ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Novo Nordisk (NYSE:NVO) rose to its highest level in over two months Monday after a media report said hedge fund Parvus Asset ...

Novo Nordisk (NVO) shares hit their highest level in over two months following a Financial Times report that activist hedge ...

(Reuters) -European stocks were steady on Tuesday, shrugging off modest losses from the previous session, as investors stayed ...

Hedge fund aims to influence CEO appointment as drugmaker battles share price slump and competition from Eli Lilly.

European stocks were steady on Tuesday, shrugging off modest losses from the previous session, as investors stayed on edge ...